Home|Journals|Articles by Year|Audio Abstracts
 

4 articles found.


Publishing Year(s)



Click to Change Year(s)

Journal(s)



Click to Change Journal(s)

  1. Attenuation of cisplatin-induced hepatotoxicity by nanocurcumin through modulation of antioxidative and anti-inflammatory pathways
    Melva Louisa, Azis M Putera, Antasena A. Sidqi, Dimas Kirana Mahaputra, Ekida R. Firmansyah, Muhammad F. Ammar, Natasha Talya, Ni Nyoman Berlian Aryadevi, Ni Made Dwi Sandhiutami, Dewi Sukmawati, Vivian Soetikno
    Journal of Applied Pharmaceutical Science. 2023; 13(3): 60-70.
  2. Clinical Characteristic and Outcomes of Aphakic Iris-Claw Intraocular Lens Implantation (Artisan) in Prof Ngoerah General Hospital on August 2019-July 2022
    Siska, Ni Luh Putu Nurindah Sukmawati, I Wayan Gede Jayanegara, AA Mas Putrawati Triningrat, IB Putra Manuaba
    International Journal of Medical Reviews and Case Reports. 2022; 6(15): 61-66.
  3. Vitamin E ameliorates testicular histological features and androgen binding protein levels in testicle of rats induced by allethrin
    Yofa Sukmawati , Dessy Arisanty, Alimuddin Tofrizal, Arni Amir
    Journal of Advanced Veterinary and Animal Research. 2019; 6(4): 486-491.
  4. Clofazimine attenuates colitis-associated colon cancer through β-catenin signaling pathway in the AOM/DSS mice models
    Salbiah Ridwan, Anton Bahtiar, Dewi Sukmawati, Sirithon Siriamornpun
    Journal of Applied Pharmaceutical Science. 2024; 14(3): 71-80.


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.